MedTrace Logo

Serbian Smoking Reduction/Cessation Trial (2SRT)

NCT00601042 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 319

Last updated 2013-12-11

No results posted yet for this study

Summary

The study aims to establish if a low-nitrosamine, smokeless tobacco product (Swedish snus) can help adult smokers to reduce and eventually completely quit smoking.

Conditions

  • Cigarette Smoking

Interventions

OTHER

Swedish snus (smokeless tobacco)

Snus in sachets 1.0 g or 0.5 g, 2 flavors. Usage ad libitum.

OTHER

Onico

Tobacco-free, nicotine-free placebo snus, 2 sachet sizes (1.0 g, 0.5 g), 2 flavors (same as in the experimental arm). Usage ad libitum.

Sponsors & Collaborators

  • Swedish Match AB

    lead INDUSTRY

Principal Investigators

  • Gordana Joksic, Ph D · Institute for Nuclear Research "Vinca", Belgrade, Serbia

  • Robert Nilsson, Ph D, Prof · Stockholm University, Stockholm, Sweden

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • Serbia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00601042 on ClinicalTrials.gov